![Tom Hochuli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Tom Hochuli
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Vibalogics GmbH
![]() Vibalogics GmbH BiotechnologyHealth Technology Vibalogics GmbH develops therapeutic and prophylactic vaccines and biological products. The company is headquartered in Cuxhaven, Germany. | Direktor/Vorstandsmitglied | 01.01.2020 | - |
Vorstandsvorsitzender | 01.01.2020 | - | |
Be The Match Biotherapies
![]() Be The Match Biotherapies BiotechnologyHealth Technology Part of The Marrow Foundation, Be The Match Biotherapies is a company that partners with cell and gene therapy companies to provide customizable services to support the entire end-to-end cell therapy supply chain. The company is based in Minneapolis, MN. The company has extensive experience providing cellular source material consented for research, clinical and commercial use. The company was founded in 2016. The CEO is Amy L. Ronneberg. | Präsident | 30.01.2024 | - |
Karriereverlauf von Tom Hochuli
Statistik
International
Deutschland | 2 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 1 |
Chief Executive Officer | 1 |
President | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Vibalogics GmbH
![]() Vibalogics GmbH BiotechnologyHealth Technology Vibalogics GmbH develops therapeutic and prophylactic vaccines and biological products. The company is headquartered in Cuxhaven, Germany. | Health Technology |
Be The Match Biotherapies
![]() Be The Match Biotherapies BiotechnologyHealth Technology Part of The Marrow Foundation, Be The Match Biotherapies is a company that partners with cell and gene therapy companies to provide customizable services to support the entire end-to-end cell therapy supply chain. The company is based in Minneapolis, MN. The company has extensive experience providing cellular source material consented for research, clinical and commercial use. The company was founded in 2016. The CEO is Amy L. Ronneberg. | Health Technology |
- Börse
- Insiders
- Tom Hochuli
- Erfahrung